Statement Of Cash Flows [Abstract]

Sopharma Trading AD - Filing #6022483

Concept 2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
As at
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Profit (loss)
- BGN
- BGN
29 208 BGN
29 208 BGN
- BGN
- BGN
- BGN
- BGN
- BGN
- BGN
9 080 BGN
- BGN
9 080 BGN
- BGN
Interest paid, classified as operating activities
8 006 BGN
4 419 BGN
Other inflows (outflows) of cash, classified as operating activities
1 368 BGN
1 073 BGN
Cash flows from (used in) operating activities
47 956 BGN
18 580 BGN
Cash flows from (used in) investing activities [abstract]
Proceeds from sales of property, plant and equipment, classified as investing activities
347,000 BGN
1 371 BGN
Purchase of property, plant and equipment, classified as investing activities
10 327 BGN
5 738 BGN
Purchase of intangible assets, classified as investing activities
4 514 BGN
3 486 BGN
Cash advances and loans made to other parties, classified as investing activities
1 956 BGN
1 958 BGN
Cash flows from (used in) investing activities
25 797 BGN
12 149 BGN
Cash flows from (used in) financing activities [abstract]
Payments of lease liabilities, classified as financing activities
17 312 BGN
15 064 BGN
Interest paid, classified as financing activities
290,000 BGN
294,000 BGN
Cash flows from (used in) financing activities
15 879 BGN
11 287 BGN
Increase (decrease) in cash and cash equivalents before effect of exchange rate changes
6 280 BGN
4 856 BGN
Effect of exchange rate changes on cash and cash equivalents [abstract]
Effect of exchange rate changes on cash and cash equivalents
1,000 BGN
4,000 BGN
Cash and cash equivalents
13 112 BGN
6 833 BGN

Talk to a Data Expert

Have a question? We'll get back to you promptly.